DLA Piper advises ResApp on $100m proposed sale to Pfizer

The firm also assisted ResApp on a non-exclusive licencing agreement

DLA Piper advises ResApp on $100m proposed sale to Pfizer

DLA Piper has advised ASX-listed ResApp Health Limited on its binding scheme implementation deed with Pfizer Australia Holdings Pty Limited, a wholly owned subsidiary of Pfizer Inc.

Pursuant to the deed, Pfizer proposed to acquire 100% of the shares in ResApp by way of a scheme of arrangement for $0.115 per share in cash, representing a total equity value of approximately $100m.

“The proposed acquisition recognises the years of dedicated work by the ResApp team to build ResApp into a leader in audio-based analysis of respiratory health,” ResApp CEO and managing director Tony Keating said. “We believe that the material premium and certainty of an all-cash consideration is an attractive outcome for our shareholders.”

DLA Piper also assisted ResApp on its non-exclusive licence agreement, under which it will collaborate with Pfizer on the research and development of COVID-19 related products for a period of six months, subject to two extensions of three months each. Partners James Nicholls, Greg Bodulovic and Fleur Gibbons led the firm’s public M&A, anti-trust, and IP teams on both transactions.

The partners were assisted by special counsel Chantal Encavey; senior associates Nicole Breschkin and Kit Lloyd; solicitors Kirsty Hall and Emily Donley; and graduate Joshua Scoles.

Based in Brisbane, ResApp is a leading digital health company that develops smartphone applications for the diagnosis and management of respiratory diseases.

Recent articles & video

ATB boosts leadership with seven principals

Sparke Helmore lures Clayton Utz insurance specialist

Vienna Kang Advocates executive slams CBA's decision to strike

Hunt & Hunt welcomes new principal from HWL Ebsworth

arch.law founder: A more entrepreneurial mindset can be a game changer

Former Japan FTC secretary general joins Baker McKenzie

Most Read Articles

Moray & Agnew adds to domestic building insurance expertise with returning talent

Leading boutiques in Australia for 2022 revealed

HSF Sydney goes green in transition to clean energy ops

Law firm profitability hits new low in index history